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Abstract. The prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted 
to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. 
The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the 
most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates 
indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and 
to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish 
this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also 
summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.
Key words: myopia, pathologic myopia, preventive medicine, blindness, time spent outdoors, myopia reduction interventions, 
atropine, orthokeratology
АКТУАЛНИ НАСОКИ В КОНТРОЛА И ПРЕВЕНЦИЯТА НА МИОПИЯТА ОТ ЕВРОПЕЙСКОТО 
ОФТАЛМОЛОГИЧНО ОБЩЕСТВО И МЕЖДУНАРОДНИЯ ИНСТИТУТ ПО МИОПИЯ
Резюме. Честотата на миопията се увеличава изключително много в световен мащаб. Броят на хората с късогледство 
до 2020 г. е от порядъка на 2.6 млрд. души, а до 2050 г. се смята, че броят им ще нарасне до 4.9 млрд. души, освен ако не 
се предприемат необходимите мерки за превенция. Броят на пациентите с високостепенна миопия също значително 
нараства и се предполага, че патологичната миопия в бъдеще ще бъде най-честата причина за невъзвратима загуба на 
зрение и слепота както в Европа, така и по света. Тази статистика показва важността да се намали броят на патологич-
ната миопия чрез различни профилактични мерки, както и да се намали скоростта на прогресия на късогледството. 
Поради важността на проблема Европейското офталмологично общество реши да публикува актуалните препоръки 
за превенция и контрол на миопията. Патогенезата, епидемиологията и рисковите фактори, както и терапевтичните 
възможности са дискутирани в детайли.
Ключови думи: миопия, патологична миопия, превантивна медицина, слепота, занимания на открито, интервенции за 
редукция на миопията, атропин, ортокератология 
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Introduction
Myopia is recognized as a significant global 
public health issue, expected to affect an increas-
ing number of people in the next decades.1 Pa-
thology such as myopic maculopathy and optic 
neuropathy in highly myopic eyes can cause sig-
nificant irreversible visual impairment and blind-
ness.1-3 Besides, myopia increases the risk of oth-
er pathological ocular changes such as cataract, 
glaucoma, and retinal detachment, all of which 
can cause irreversible vision loss.4,5 Significant 
disease associations exist even at low and mod-
erate levels of myopia. Current evidence suggests 
that there is no safe threshold level of myopia for 
any of the known ocular diseases linked to myo-
pia.6,7
The importance of the increase in the preva-
lence of myopia and its sequelae has been well 
documented particularly in East Asian countries 
that have experienced the most pronounced in-
crease in myopia prevalence. Consequently, the 
experience in preventing the development and 
progression of myopia in children and adoles-
cents is more advanced in East Asia. The preva-
lence of myopia also increased in Europe in re-
cent decades and reached the level of 45-50% 
in the 25-29 years old age group.8 Thus, Europe 
is becoming aware of the importance of myopia 
both as a public health issue and as a significant 
socioeconomic burden.
The International Myopia Institute (IMI) with 
its group of 85 multidisciplinary experts in the 
field has recently published a series of white pa-
pers on the pathogenesis of myopia including the 
results of experimental studies,9 genetics,10 and 
the results of clinical studies including the out-
come of randomized controlled trials.11 Based on 
the IMI White Papers,11 the main aim of this ar-
ticle is to increase awareness and to provide rec-
ommendations for European ophthalmologists 
to prevent the development and progression of 
myopia in children and adolescents.
Definition and classification
To be consistent with international standards, 
the definitions and classification of myopia as 
used in this article follow those described by the 
IMI in the IMI White Papers.
Epidemiology
According to Holden et al.1 quoted in the 
World Report on Vision published by the World 
Health Organization (WHO) in October 2019, the 
estimated number of people globally with myo-
pia in 2020 was predicted to be 2620 million, 
with a further expected increase to 3361 million 
by 2030. The number of individuals with high 
myopia was also expected to increase substan-
tially from 399 million in 2020 to 516 million by 
2030.1,46 Both these estimates assume no impact 
of interventions intended to slow down myopia 
progression.
This means that pathological myopia is pre-
dicted to become the most common cause of irre-
versible vision impairment and blindness world-
wide, and the prevalence estimates indicate the 
importance of reducing the global burden of myo-
pia by means of myopia reduction interventions
The predicted prevalence of myopia by 2050 
is 65% of the population in Asia, 56% in Western 
Europe, 54% in Central Europe, and 50% in East-
ern Europe1.
Many studies have reported substantial varia-
tions in the prevalence of myopia between differ-
ent ethnic groups and different age groups.47
Prevalence of myopia in different  
ethnic groups
The myopia burden is highest in East Asia 
and the high-income countries of the Asia-Pacific 
region (51.6% and 53.4% prevalence in 2020, 
respectively) but the prevalence is also high in 
Europe (Western Europe: 36.7%, Central Europe: 
34.6%, and Eastern Europe: 32.2%).1,48 An ear-
lier meta-analysis from fifteen population-based 
adult cohorts and cross-sectional studies across 
Europe determined an age-standardised preva-
lence of 30.6% for myopia.49 The peak prevalence 
of myopia was identified in the 25-29 years age 
group (47.2%) although the prevalence of high 
myopia was relatively low in Europe, with an age-
standardised estimate of 2.7%.49
A recent review by Grzybowski et al. showed 
that the prevalence of myopia in school-aged 
children was 73% in East Asia and 42% in North 
America. A low prevalence (under 10%) was de-
scribed in African and South American children.8 
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In groups of White ethnicity there was no clear 
evidence of differences in myopia prevalence be-
tween studies of recent decades from Europe, the 
USA and Oceania.50 (Tables 3 and 4).
Prevalence of myopia across age 
groups
An early age of onset of myopia appears to be 
the strongest predictor of high myopia in both 
Asians and White children.71-74
It was recently shown that parental myopia 
was associated with a greater risk of early-onset 
myopia in Asian, Hispanic, non-Hispanic white, 
and African American children.75
In children younger than 6 years of age the 
prevalence of myopia is low. This is the case even 
in Asia where the prevalence of myopia is consid-
ered to be critically high in young adults (Table 
5).
The prevalence of myopia increases markedly 
from approximately 6 years of age. When com-
paring the indicators for the last 45 years (from 
1971 to 2016), the frequency of myopia in Novo-
sibirsk school-children aged 7-10 years increased 
5.1 times (from 4.5%to 23.0%), 11-14 years in-
creased 3.8 times (from 10.5% to 40.0%), and 
15-18 years increased 2.1 times (from 21.5% to 
45.0%). It follows that the highest rate of onset of 
myopia is currently observed in children aged 7 
to 10 years.79,80 In the Correction of Myopia Eval-
uation Trial (COMET) study 426 ethnically di-
verse (African, Asian, Hispanic,Mixed, and White) 
myopic children were followed-up annually for 
Table 3. Prevalence of myopia in children in Europe.





Matamoros51 2015 0-9 France 1781 ≤ −0.5 19.6
Tideman52 2017 6 Netherlands 5711 ≤ −0.5 2.4
Enthoven et al.53 2020 9 Netherlands 5074 ≤ −0.5 11.5
Rudnicka et al.54 2010 10-11 United Kingdom 233 ≤ −0.5 3.4
O’Donoghue et al.55 2015 12-13 Northern Ireland 661 ≤ −0.5 17.7
Tideman et al.56 2020 13 Netherlands 3600 ≤ −0.5 22.2
Matamoros51 2015 10-19 France 8289 ≤ −0.5 42.7
Lundberg57 2017 Mean: 15.4 Denmark 307 ≤ −0.5 33.6cycloplegia: 17.9
Hagen et al.58 2018 16-19 Norway 393 ≤ −0.5 13
Table 4. Prevalence of myopia in teenage Asian children.








Lam et al.59 2004 13-15 Hong Kong 289 ≤ −0.5 87.2
Matsumara et al.60 1999 17 Japan 346 ≤ −0.5 66.0
Wu et al.61 2013 17 China 6026 ≤ −0.5 84.6
Lin et al.62 2004 16-18 Taiwan 2474 < −0.25 84.0
Jung63 2012 19 South Korea 23,616 < −0.5 96.5
Lee et al.64 2013 19 South Korea 2805 ≤ −0.5 83.3
Koh et al.65 2014 Mean: 19.8 Singapore 28,908 < −0.5 81.6
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at least 6 and up to 11 years to assess, amongst 
other things, when myopia seemed to stabilize. 
Nearly half (48%) of the children had stable myo-
pia by age 15 years, 77% by 18 years and 90% by 
the age 21 years. There is evidence for myopia to 
have stabilized in most myopic individuals by the 
age 24 years, except in high myopes.83-85 In a 23-
year follow-up study of Finnish myopic children 
from mean age of 11 years at baseline, the adult-
hood myopic progression from the mean age of 
24 years 8 years onwards was ≥ 1.00 D in 17.9% 
of cases and mean annual change was -0.05 ± 
0.09 D.86
Other studies show a decline in progression 
rate with increasing age in young myopes of both 
European and Asian ethnicity.69,87,88 In White Eu-
ropean children, average yearly progression rates 
for myopia and axial length were −0.41 D and 
−0.30 mm respectively between 6 and 16 years 
of age and −0.16 D and 0.15 mm respectively be-
tween 12 and 22 years.88
In 2000, Holden et al. showed that the greatest 
proportion of myopic people was between 10 and 
39 years of age.1 A European study also reported 
that myopia was most common in younger par-
ticipants (47.2%), with those aged 25-29 years 
having a prevalence almost double (27.5%) that 
of those of middle and older age (55-59 years).89
However, given the predicted increases in 
prevalence discussed above, the distribution of 
myopia in the population is expected to widen by 
2050, with a significant proportion of the popula-
tion exhibiting myopia from 10 years of age all the 
way through to 79 years of age; with the bulk of 
late onset (16 years or older) myopia, reflecting 
the significant lifestyle changes, mostly intensive 
near work over the past 10 to 25 years.1,73,90 This 
may well be exacerbated by changes in working 
patterns following the Covid-19 pandemic (in-
creased time indoors, increased time on electron-
ic devices, etc.).
Based on a meta-analysis from 2015, there is 
a clear trend of higher myopia prevalence in the 
last 20 to 30 years across Western and Northern 
Europe.89,91 In contrast, while the prevalence of 
myopia is reported to have been rising around the 
world, a similar trend in Southeast Norway ap-
pears to be absent.58 Neither in Denmark, where 
nearly 140 years of myopia research did not find 
a convincing change in prevalence of myopia.92 
Asian ancestry does not inevitably lead to myo-
pia, since the prevalence of myopia in these areas 
was much lower two or three generations ago.88,93 
This suggests that environmental and social fac-
tors must be involved in the promotion of myopia 
in modern populations.
At the current time, the incidence of myopia 
is increasing in younger age groups, which means 
that prevalence rates in older adults are gener-
ally lower.47,51,91,94 However, a bimodal pattern 
was observed in the prevalence of myopia among 
subjects of African-American ethnicity and in the 
population of Singapore. In both groups aged 40+ 
years, the prevalence was also highest among in-
dividuals in their forties and seventies.95,96 A simi-
lar bimodal pattern was found in France, but the 
peak of myopia prevalence was in people in their 
twenties and above eighties.51 The bimodal distri-
bution is probably due to the increase of the axial 
myopia among younger people, and secondary 
refractive myopization due to nuclear cataract in 
elderly people.47
Interventions for controlling myopia
The main measures that can be taken for the 
prevention of the development of myopia and for 
the reduction of the progression of myopia in-
clude: (1) Public health (lifestyle) interventions 
– optimization of environmental influences, (2) 
Pharmacological approach with the topical appli-
Table 5. Prevalence of myopia in younger ages (< 9 years)







Ma et al.76 2016 3 Shanghai, China 8267 ≤ −0.5 1.8
Guo et al.77 2017 3 China 1127 ≤ −0.5 0.0
Wu et al.61 2013 4 China 6026 ≤ −0.5 1.2
Li et al.78 2014 5-9 Northern China 1675 ≤ −0.5 0.9
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cation of atropine eye drops, (3) Optical devices 
including multifocal spectacles and multifocal 
contact lenses that can have aspheric or discrete 
dual-focus designs, and orthokeratology.
There is high quality evidence that all methods 
slow the development or progression of myopia 
although the efficacy is different for the various 
interventions.
Optimization of environmental 
influences
Outdoor activities. Many studies (including 
randomized clinical trials) highlight the protec-
tive role of increased outdoor/sport time on 
myopia prevention.115, 155, 157, 172-177 In a meta-anal-
ysis, every additional hour of outdoor time per 
week lead to a reduction in the risk of myopia 
by 2%.178 The chance of becoming myopic is re-
duced by around one third if time spent outdoors 
is increased from 0 to 5 h per week to 14 or more 
hours per week.172,179
The mechanism of increased outdoor time as 
an intervention for myopia control is not com-
pletely clear. Spending time outdoors itself, in-
stead of physical activities outdoors, has been 
suggested to be the protective factor.150,180 Pat-
terns of defocus on the retina by three-dimen-
sional structures of the environment have also 
been proposed as a possible mechanism of pro-
tection during outdoor activities.6
The protective effect of outdoor activity on 
myopia development in children seems to be 
partly mediated by the light-stimulated release 
of dopamine from the retina, since increased do-
pamine release appears to inhibit increased axial 
elongation.179,181 The absence of ultraviolet (UV) 
light may provoke axial myopia.182 According to 
Flitcoft et al., compared to the spatial properties 
of the natural world, man-made (urban) envi-
ronments and indoor environments have spatial 
features similar to those than created by diffus-
ing filters that induce form deprivation myopia 
in animal models.163 The spatial frequency com-
position of the constructed environment, both 
indoors and outdoors, is therefore different from 
the natural world. Enhancing spatial frequency 
content of the visual scene may help to limit myo-
pia.
Evidence linking time outdoors to the preven-
tion of myopia is stronger than that linking it to 
slowing the progression of existing myopia.179
Wu et al. have shown that participation in out-
door activities during school recess (10-20 min in 
both the morning and afternoon) has a significant 
effect on myopic shift in non-myopic children but 
not on the myopic progression of children with 
myopia.175 Confirming the above relationship, an-
other study did not detect an effect of near work 
or time outdoors on the progression of myopia in 
those with established myopia.174 However, other 
studies have shown faster myopia progression 
during the darker winter than the brighter 
summer months.183,184
Vitamin D. A number of studies have reported 
lower levels of serum vitamin D in myopes com-
pared with non-myopes.185-189
Lower 25-hydroxyvitamin D concentration in 
serum was associated with longer AL and a high-
er risk of myopia in young children, and the effect 
was independent of outdoor exposure time. As-
sociations were not different between European 
and non-European children.185 In another study, 
total vitamin D and D3 were biomarkers for time 
spent outdoors, however there was no evidence 
they were independently associated with future 
myopia.190
In a study by the CREAM consortium, a Men-
delian randomization analysis did not support 
a direct involvement of vitamin D with myo-
pic refractive error, as individuals genetically 
predisposed to lower 25(OH)D levels were not 
more myopic.152
Indoor lighting. In a Chinese study, increasing 
the light levels from approximately 100 to 500 lux 
in school class-rooms had a significant effect on 
myopia onset, refraction and axial elongation.149 
Another more recent multivariate logistic analysis 
reported that time spent with a light intensity of 
> 3000 lux was a protective factor for myopia in 
China.158
Studies are investigating if achieving light lev-
els indoors similar to the outdoor environment 
can reduce the incidence and progression of myo-
pia.163,191 Torii et al. examined short wavelength 
violet (360-400 nm wave-length) light which is 
absent in indoor environments and may play a 
role in the inhibition of myopia progression.151 
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They showed that over a 1-year period, children 
who wore violet light transmitting contact lenses 
had significantly less axial length elongation com-
pared to those wearing violet light blocking eye-
glasses.151
During the last few years, light-emitting dio-
de (LED) lights have been designed as a new ge-
neration of task lights instead of traditional light 
sources. A cross-sectional-study, based in China, 
determined the association of the types of lamp 
for homework (including incandescent lamp, 
fluorescent lamp, and LED lamp) with the preva-
lence of myopia in young teenagers. Using LED 
lamps was associated with more myopic refracti-
ve error and longer axial length.192
Moreover, the French Agency for Food, En-
vironmental and Occupational Health and Safety 
(ANSES) recommended avoiding the use of LED li-
ght sources emitting cold-white light with a strong 
blue component in places frequently used by child-
ren, to prevent possible photochemical damages 
and photoreceptors loss. ANSES recommends 
limitation of the sale of LEDs for domestic use.193
Conclusion environmental influences: 
Near work indoor and outdoor activity play im-
portant roles in the development of myopia and 
in the prevention of myopia, respectively. There 
is strong evidence that less near work and more 
outdoor activity provide protection against myo-
pia development in the human eye.
Time outdoors itself, rather than physical 
activity outdoors, has been suggested to be the 
protective factor.150,180 The link between time 
outdoors in the prevention of myopia is stronger 
than the link between time outdoors and slowing 
of the progression of existing myopia.179
Optical
Spectacles. Wearing spectacles is non-invasive 
and generally well-tolerated.
Undercorrection. Undercorrection of myopia 
with spectacles has been common practice for 
many years. The theory is to reduce myopia pro-
gression by reducing the accommodative demand 
during near work. Current evidence suggests this 
is not beneficial and can be harmful.
An early non-randomized trial from 1965 
found that undercorrection slowed the progres-
sion of myopia.194
In another study from 2017, over a period 
of 2 years, 12-year-old Chinese children with no 
correction had slower myopia progression (diff: 
0.29 D) and less axial elongation (0.08 mm) than 
children with full correction suggesting myopic 
defocus might act as an inhibitor of eye growth 
in humans.195
However, other studies examining undercor-
rection found just the opposite, namely either an 
increase in myopia progression or significantly 
more baseline myopia and longer axial length in 
children with undercorrection than in children 
with full correction.196-198
A 1-year study of myopic Chinese children, 
wearing spectacles which either under- or fully 
corrected their myopia did not show any differ-
ences in myopia progression or axial elongation.198
Undercorrection strategies do not provide op-
timal distance visual acuity and may also lead to 
behavioural changes, such as a reduction in out-
door activities in some children which, as noted 
above, may promote myopia progression.199
As also summarized in the recent Cochrane 
and other systematic reviews, an over-correction 
or under-correction of the myopic refractive er-
ror had no strong evidence of benefits and instead 
possible risks for myopia progression200-202 
and should be avoided.
Peripheral defocus-correcting spectacle lens-
es. Studies have assessed different types of novel 
spectacle lens designs aimed at modulating the 
relative peripheral defocus in Asian children, 
with no differences in the rate of progression of 
myopia or axial elongation when compared with 
single vision (SV) control groups.203 Aspheriza-
tion of the distance zone added to progressive ad-
ditional lenses (PALs) did not enhance their ther-
apeutic efficacy in slowing myopia progression.204
Moreover, novel spectacle lens design to re-
duce peripheral hyperopic defocus was reported 
to demonstrate a reduction in myopia progres-
sion in the younger subgroup of children aged 6 
to 12 years with a parental history of myopia, in 
a 1-year trial.205
However, this beneficial effect was only ob-
served in an exploratory subgroup analysis that 
had insufficient statistical power to produce de-
finitive results.
More recently, a specially designed ‘compet-
ing defocus’ spectacle lens, called Defocus In-
24
БЪЛГАРСКИ ОФТАЛМОЛОГИЧЕН ПРЕГЛЕД, 2021, 65, бр. 2 25
corporated Multiple Segments (DIMS) spectacle 
lens has been used for myopia control in a 2-year 
randomized trial by Lam et al.206 This lens design 
has a central optical zone for correcting refractive 
error and multiple segments of constant myopic 
defocus (+3.50 D) surrounding the central zone. 
This enables the lens to provide clear vision and 
myopic defocus simultaneously for distance, in-
termediate or near. The results from the clinical 
trial showed that children of East Asian ethnic-
ity wearing DIMS lenses had 52% less myopia 
progression (average −0.41 ± 0.06 D in the DIMS 
group vs. average −0.85 ± 0.08 D in the single vi-
sion group) and 62% less axial elongation (mean 
difference 0.34 ± 0.04 mm) compared with single 
vision spectacle lenses and about 21.5% of the 
DIMS lens wearers had no myopia progression 
during the 2-year long study period while among 
the controls this was the case in only 6%.206
Conclusion spectacle lenses: Undercor-
rection of myopia is not recommended as it in-
creased myopia progression slightly (low-cer-
tainty evidence, Cochrane-2020)201 and did not 
slow myopia progression as previously thought. 
Bifocal spectacles or progressive addition lenses 
versus single vision lenses (SVLs) yielded a small 
effect in slowing myopia progression (moderate-
certainty evidence).201 Studies evaluating differ-
ent peripheral defocus-correcting lenses versus 
SVLs reported inconsistent results for refractive 
error and axial length outcomes (low-certainty 
evidence)201 although results for DIMS spectacles 
are promising.201
Contact lenses
Soft contact lens (SCL). There is no substantial 
evidence in the literature that conventional soft 
contact lens wear leads to either slower or faster 
myopia progression than spectacle wear.199, 216-
218 Rigid gas permeable (RGP). In some studies, 
rigid gas permeable lenses were reported to slow 
myopia progression in children,219-221 but more 
recent, well-designed studies showed that the use 
of these lenses did not impact axial elongation and 
that the apparent control of myopia progression 
observed with RGPs was most likely induced by 
temporary corneal flattening.222,223
Guidelines for clinical management 
and control of myopia in children
Selection of myopia control methods
Based on the child’s individual and paren-
tal factors, it should be possible to offer a strat-
egy against myopia progression. Decision to treat 
should be based on age of onset and axial length 
or refraction at a given age.285 If there is a suspi-
cion of any underlying ocular disease, additional 
examinations are recommended (corneal topog-
raphy, electrophysiology, retinal imaging, or ge-
netic testing).337
Lifestyle advices
Indoor and near work activity. Excessive near 
work may influence the development and pro-
gression of myopia.11,100,340 Close reading distance 
(20-25 cm) and continuous reading (> 45 min), 
head tilt, closer nib-to-fingertip distance (which 
means greater head tilt) have been associated 
with greater odds of myopia progression.158,340-342
In a 23-year follow-up study of Pärssinen, 
myopic progression was highest among those 
whose reading posture in childhood was sitting 
and lowest among those who reported reading 
in suppine position.343 Short reading distance in 
childhood predicted higher adulthood myopia 
among females. Time spent on reading and close 
work in childhood was related to myopic progres-
sion during the first 3 years but did not predict 
adulthood myopia.86
Children should not be prevented from par-
ticipating in near work activity, but attention 
should be given to the following measures: regu-
lar breaks, appropriate reading distances without 
head tilt, and near-to-distance fixation changes 
while reading with sufficient outdoor activi-
ties.339 The Erasmus Myopia Research Group in 
the Netherlands recommends complete absence 
of close-up screen use for children up to 2 years 
old; maximum 1 h day, for children up to 5 years, 
and a maximum of 2 h day for children aged 5-12 
years.179,337,344
Time spent outdoors and lighting. Spending 
time out-doors without requiring physical activ-
ity or direct sunlight exposure appears to have a 
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protective effect against myopia onset but not for 
myopic progression.86,153,339
Every additional 1-h of outdoor time per 
week is associated with a reduction in the risk of 
myopia by 2%.178 The chance of becoming myopic 
is reduced by around one third if time spent out-
doors is increased from 0 to 5 h per week to 14 or 
more per week.172,179
A minimum of 8 to 15 h of outdoor activity per 
week is recommended for school aged children 
to achieve clinically meaningful protection from 
myopiagenic stimuli.157,172,174,176,178,179,345 Individu-
als who are at risk of developing myopia should 
try to maximise natural lighing and to increase 
time spent outdoors.149,150,158,339 To maximise in-
door lighting149,150,339 use incandescent light bulbs 
rather than fluorescent or LED lighting.192,334
Nutritional advice. Nowadays a lot of health 
issues may be connected to nutritional habits. 
Therefore, parents may enquire whether a change 
in dietary habits could decrease the probability of 
eye diseases.
In Chinese schoolchildren higher saturated 
fat and cholesterol intake were associated with 
longer axial length.346 As noted above, treatment 
with caffeine metabolite seven-methylxanthine 
has small effect on eye growth in children.302
Although caffeine-like stimulants may be part 
of nutritional advice for myopes in the future, 
there is no current high-level evidence to support 
nutritional treatments for myopia control.339
Refractive corrections. Spectacle lenses are 
non-invasive, simple, and affordable technique 
for optical correction of refractive errors, such as 
myopia.
Children should be encouraged to wear their 
myopic correction full time, as undercorrection 
of myopia has been shown in some studies to in-
crease myopia progression.196,197,198
Decreasing full distance myopic refractive er-
ror correction during near work will reduce ac-
commodative demand and accommodative lag.339 
However, in a 3-year randomized controlled clini-
cal trial mildly myopic school children aged 9-11 
years showed significantly less myopia progres-
sion when they wore full correction continuously 
than wearing spectacles only for distant vision. 
Neither the use of bifocals nor avoiding the use 
of spectacles in reading slows myopia progres-
sion.211 Spectacle with peripheral defocus designs 
such as the DIMS lenses206 should be considered 
over SV lenses in progressing myopes.
Contact lenses play an important role in myo-
pia control. This includes ortho-K and regulatory 
approved soft contact lenses for myopia control, 
and studies are ongoing comparing the effect on 
myopia control of various recently developed 
contact lens types. Based on a meta-analysis, 
ortho-k and soft lenses for myopia control offer 
similar levels of axial length control.243
Arecent report of American Academy of Oph-
thalmology concluded that ortho-K may be effec-
tive in slowing myopic progression for children 
and adolescents, however, safety remains a con-
cern because of the risk of potentially blinding 
microbial keratitis from contact lens wear.347
Customizing ortho-K lens designs to limit the 
central treatment zone may help to bring more 
plus power inside the pupil and achieve a greater 
shift in relative peripheral myopia.348-350 However, 
such approaches need to be evaluating in ran-
domized controlled trials.
If customization of the ortho-K lenses is not 
possible, soft multifocal lenses are preferable for 
any patient who has less than 2.00 D of refractive 
error. Also, patients who have a photopic pupil size 
smaller than 4.5 mm will be better served by a soft 
multifocal lens with a design that is independent 
of pupil size. Using soft multifocal contact lenses, 
the highest plus power that does not generate blur 
at distance without overminusing the original cy-
cloplegic refractive power, was recommended by a 
recent myopia control summary.334
For orthokeratology lens wear should be en-
couraged every night for a minimum of 8 h per 
night to maximize correction for best-unaided vi-
sion during waking hours.339 The treatment effect 
of multifocal soft contact lens (MFSCL) is likely 
to be positively correlated with wearing time.230 
Full time use of MFSCLs is recommended during 
school hours and for schoolwork at home, provid-
ing greater myopia control efficacy.339 Preferably, 
regulatory approved myopia controlling new de-
signs, bifocal, progressive additional lenses (PAL), 
or single-vision spectacles may be prescribed for 
when children are not wearing their contact lens-
es.339
Another possibility is to add spectacles to 
supplement contact lens wear when accommoda-
tion is deficient.334
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Children, who are intolerant of contact lenses 
or showing high exophoria at near, could be pre-
scribed (prismatic) bifocal or anti-myopia spec-
tacles. Fast progressors may not be treated suf-
ficiently with low-add-power lenses, particularly 
in case of accommodative dysfunction.
Spectacle lenses are also the first option of 
care in very young children (who are unable to 
wear contact lenses due to access or cost), any 
situations that associated with poor hygiene con-
ditions, or if children grew up in locations with no 
or only limited access specialized eye care.351
Atropine therapy. A report from American 
Academy of Ophthalmology concluded that the 
use of atropine to prevent myopic progression is 
supported by Level I evidence.352 The World So-
ciety of Pediatric Ophthalmology and Strabismus 
in its Myopia Consesnus Statement argued that 
atropine 0.01% appears to offer an appropriate 
risk-benefit ratio, with no clinically significant 
visual side effects balanced against a reason-




In a recent protocol developed by Chia and 
Tay, 353 children are first started on a lower dose 
of atropine with a plan to increase the dose as 
necessary. Once medication is started, progres-
sion (in terms of refraction and axial length) 
should be monitored every 6 months, for at least 
2 years. Based on the protocol from the Nether-
land,93,337 axial length and gender-specific growth 
curve charts are used to evaluate the risk of myo-
pipa/high myopia. Children with risk of myopia 
at the 75th percentile or above are then started 
on atropine 0.5% eye drops.337
The ATOM 2 study showed that 0.01% atro-
pine resulted in a 60% risk of a refractive error 
rebound effect in children aged 8-10 years, com-
pared to 30% at age 10-12 years and 8% after the 
age of 12 years.281 The change in spherical equiva-
lent was greater than the change in axial length 
and not directly associated with the change in 
axial length alone.281 This suggests that in chil-
dren younger than 12 years who showed no pro-
gression in the past year, atropine 0.01% may be 
slowly tapered by reducing drop frequency (by 
1-2 days/week each year). However, if children 
are older than 12 years, then the frequency of 
eye drops could be tapered more quickly (by 1-2 
days/week every 6 months). Using this regime, 
most children will be off medication by about 14-
15 years of age.353
The Low-Concentration Atropine for Myopia 
Progression (LAMP) study recommends the use 
of 0.05% atropine rather than 0.01%, as the low-
er concentration allowed unacceptable levels of 
axial length progression.279In children who prog-
ress on low-dose atropine, the frequency of appli-
cation, or dose could be increased (using atropine 
0.01% twice a day; or using a higher concentra-
tion, 0.05%, 0.1%, 0.5%, or 1%). Increasing the 
dose of atropine needs to be balanced against 
side effects of loss of accommodation and glare/
aberrations from large pupil. Once an adequate 
control of myopia is achieved, medication can be 
continued till the child reaches teenage years and 
then tapered as required. There are some chil-
dren (11%), however, who may progress rapidly 
even on 0.5% atropine.331 If this occurs, then the 
possibility of stopping treatment or trying other 
treatment modalities should be discussed. Even 
after stopping treatment, it may be necessary to 
monitor children for a further 6-12 months to en-
sure that there is no further rebound.353
Patients undergoing atropine therapy will 
require distance refractive error correction. It is 
recommended that patients be prescribed their 
full distance refractive correction; however, pa-
tients may require near addition correction to al-
leviate near visual symptoms and photochromic 
lenses or additional sunglasses to relieve glare is-
sues if necessary.339
Combination therapy in practice. For patients 
using mono-therapy in the form of atropine or 
ortho-K and who still experience progression 
of myopia and axial elongation at a faster rate 
than expected, combination therapy should be 
considered. Ortho-K with low-dose atropine im-
proved myopia control by the synergistic effect 
compared with orthokeratology treatment alone, 
presumably because it increases the pupil area 
and, therefore, allows more plus power to reach 
the peripheral retina.328,330,334 The effectiveness 
and side effects of combination therapy with at-
ropine and soft myopia control contact lens is 
unknown, and should be first evaluated in pro-
spective clinical trials before being used in clini-
cal practice.
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Treatment duration
Axial length is the most important met-
ric to monitor in pre-myopic and myopic chil-
dren.93,285,334,337,338
Myopia generally progresses most rapidly 
during pre-teenager years (7-12 years), subse-
quently slowing through adolescence and adult-
hood.67,91,354 The mean age of myopia stabilization 
is around 15.6 years of age, and 95% of myopes 
stabilize by age of 24 years.83
There are some publications of myopia onset 
and progression at a later age among specific oc-
cupational groups, during university education 
courses such as medicine, law or engineering.355-357
The efficacy of some treatments may wane 
after the first 6 months to 2 years of treat-
ment.248,285,358–360 There is insufficient evidence 
that faster progressors, or younger myopes, de-
rive greater benefit from treatment.285 The same 
treatments and protocols as applied in childhood 
may be applicable in later-onset myopia, although 
the available evidence is limited.339
In case of atropine treatment parents and 
patients should be made aware that myopia pro-
gression may accelerate after stopping higher-
dose atropine usage, but despite this rebound 
effect, the level of myopia post-treatment will 
be less than it would have been without treat-
ment.280,282 The long-term use of atropine should 
only be undertaken with caution as long-term 
side effects have not been evaluated.339 It may be 
beneficial to tail off dosage or dose frequency at 
the end of treatment to minimize rebound effects. 
Although the results of the ATOM studies point 
to some loss of treatment efficacy with time, at 
least with the higher concentrations of atropine, 
a study by Wu and colleagues which involved con-
centrations between 0.05% and 0.1%, suggested 
that treatment effects with low-dose atropine can 
be maintained for up to 4.5 years.287
Discontinuation of ortho-K lens wear before 
age 14 has been shown to lead to a more rapid 
increase in axial length over a 7-month period, 
faster than concurrent single vision spectacle 
wearing controls; however, this slows again with 
resumed lens wear after another 6 months. This 
suggests that ortho-K wear should not be discon-
tinued before age 14.262
Long-term use of soft myopia control contact 
lens and ortho-K is not contraindicated if ocular 
health is maintained through regular aftercares 
and strong compliance.264,339,361 Progressive ad-
ditional lenses can also be used for vision cor-
rection, but the long-term, clinically meaningful 
myopia control effect of such lenses is small in 
comparison with contact lens corrections, ex-
cept in specific populations.145,214 Bifocal specta-
cle lenses might be a good solution for longevity 
treatment.362,363 A study of children wearing pro-
gressive addition lenses for 1 year, then switched 
to single vision glasses for 1 year showed no re-
bound.143 No rebound effect was reported with 
soft contact lens for myopia control.364
Compliance and safety issues may require 
a change in treatment modality or a halting of 
treatment. Poor tolerance of visual side effects 
may also prompt cessation or change of myopia 
control therapy.339
In conclusion, outdoor time is the most prom-
ising intervention method. There is consistent evi-
dence of a benefit of slowing myopia development 
by the use of atropine eye drops, while the optimum 
concentration of atropine and the value of a com-
bined use of atropine eye drops with optical devices 
are yet to be fully explored. There is also evidence of 
myopia control with soft multifocal contact lenses, 
orthokeratology, and new types of multifocal spec-
tacle lenses. Information is constantly evolving, so it 
is important to stay abreast of studies published in 
the peer- reviewed literature.
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